This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...